Zoloft formulary placement (correction)
Executive Summary
In a story on Medicare Part D formulary placement of antidepressants, "The Pink Sheet" incorrectly stated that Pfizer's Zoloft (sertraline) is not covered by Medco's YOURx Plan (1"The Pink Sheet" Dec. 19, 2005, p. 19). The agent is covered on Tier 2 of the plan's formulary with quantity limits. Consequently, Zoloft is covered on the lowest brand cost-sharing tier of five of the nine nationwide plans reviewed...
You may also be interested in...
Branded Antidepressants Face Challenges With Part D Formulary Positions
The Centers for Medicare & Medicaid Services appears to be interpreting its "all or substantially all" policy for Part D plan coverage of antidepressants as allowing sponsors to include the majority of agents on high cost-sharing tiers, according to analysis of plan formularies conducted by "The Pink Sheet."
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.